本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Vincerx Pharma, Inc.

0.0127
0.0000
成交量:2,709.00
成交額:34.41
市值:6.65萬
市盈率:0.00
高:0.0127
開:0.0127
低:0.0127
收:0.0127
52周最高:0.6900
52周最低:0.0002
股本:523.43萬
流通股本:494.05萬
量比:0.16
換手率:0.05%
股息:- -
股息率:- -
每股收益(TTM):-8.9799
每股收益(LYR):-15.8451
淨資產收益率:-3136.43%
總資產收益率:-197.53%
市淨率:0.03
市盈率(LYR):0.00

資料載入中...

2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/26

SEC問詢函

CORRESP [Cover] - Correspondence
2021/11/22

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/12

重要事件披露

8-K - Current report
2021/10/21

SEC問詢函

CORRESP [Cover] - Correspondence
2021/10/14

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/09/28

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/16

重要事件披露

8-K - Current report
2021/08/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/12

重要事件披露

8-K - Current report
2021/08/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/06/11

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/05/17

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/17

重要事件披露

8-K - Current report
2021/05/14

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/05/14

重要事件披露

8-K - Current report
2021/05/06

重要事件披露

8-K - Current report